Literature DB >> 24509782

Molecular mechanisms of varicella zoster virus pathogenesis.

Leigh Zerboni1, Nandini Sen1, Stefan L Oliver1, Ann M Arvin1.   

Abstract

Varicella zoster virus (VZV) is the causative agent of varicella (chickenpox) and zoster (shingles). Investigating VZV pathogenesis is challenging as VZV is a human-specific virus and infection does not occur, or is highly restricted, in other species. However, the use of human tissue xenografts in mice with severe combined immunodeficiency (SCID) enables the analysis of VZV infection in differentiated human cells in their typical tissue microenvironment. Xenografts of human skin, dorsal root ganglia or foetal thymus that contains T cells can be infected with mutant viruses or in the presence of inhibitors of viral or cellular functions to assess the molecular mechanisms of VZV-host interactions. In this Review, we discuss how these models have improved our understanding of VZV pathogenesis.

Entities:  

Mesh:

Year:  2014        PMID: 24509782      PMCID: PMC4066823          DOI: 10.1038/nrmicro3215

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  107 in total

1.  Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.

Authors:  Jenny Rowe; Rebecca J Greenblatt; Dongmei Liu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2010-03-20       Impact factor: 5.970

2.  Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.

Authors:  Jennifer H Huch; Anthony L Cunningham; Ann M Arvin; Najla Nasr; Saskia J A M Santegoets; Eric Slobedman; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

3.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

5.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

6.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

7.  Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Authors:  Adriana Weinberg; Jane H Zhang; Michael N Oxman; Gary R Johnson; Anthony R Hayward; Michael J Caulfield; Michael R Irwin; James Clair; Jeffrey G Smith; Harold Stanley; Rocio D Marchese; Ruth Harbecke; Heather M Williams; Ivan S F Chan; Robert D Arbeit; Anne A Gershon; Florian Schödel; Vicki A Morrison; Carol A Kauffman; Steve E Straus; Kenneth E Schmader; Larry E Davis; Myron J Levin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

8.  Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.

Authors:  Li Wang; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.

Authors:  Susan E Vleck; Stefan L Oliver; Mike Reichelt; Jaya Rajamani; Leigh Zerboni; Carol Jones; James Zehnder; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

10.  Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.

Authors:  Stefan L Oliver; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Charles Grose; Ann M Arvin
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

View more
  127 in total

Review 1.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

Review 2.  Evaluation of the economic burden of Herpes Zoster (HZ) infection.

Authors:  Donatella Panatto; Nicola Luigi Bragazzi; Emanuela Rizzitelli; Paolo Bonanni; Sara Boccalini; Giancarlo Icardi; Roberto Gasparini; Daniela Amicizia
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.

Authors:  Tehmina Bharucha; Damien Ming; Judith Breuer
Journal:  Hum Vaccin Immunother       Date:  2017-04-20       Impact factor: 3.452

4.  Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.

Authors:  Chelsea Gerada; Megan Steain; Tessa Mollie Campbell; Brian McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 5.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

6.  Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus.

Authors:  Nandini Sen; Gourab Mukherjee; Adrish Sen; Sean C Bendall; Phillip Sung; Garry P Nolan; Ann M Arvin
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

7.  Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs.

Authors:  Kristen Haberthur; Christine Meyer; Nicole Arnold; Flora Engelmann; Daniel R Jeske; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 8.  Investigating the biology of alpha herpesviruses with MS-based proteomics.

Authors:  Esteban A Engel; Ren Song; Orkide O Koyuncu; Lynn W Enquist
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

9.  Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Authors:  G Elias; A Souquette; S Heynderickx; I De Meester; H Jansens; P Beutels; P Van Damme; E Smits; P G Thomas; V Van Tendeloo; B Ogunjimi
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

10.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.